`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`DAIICHI SANKYO, INC., DAIICHI
`SANKYO COMPANY, LIMITED, and
`ASTRAZENECA PHARMACEUTICALS LP,
`
`v.
`
`SEAGEN INC.,
`
`Plaintiffs,
`
`Defendant.
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`C.A. No. 20-1524-LPS
`
` [PROPOSED] ORDER
`
`IT IS HEREBY ORDERED, this 28th day of April, 2021, that Defendant Seagen Inc.’s
`
`Motion to Stay or Dismiss (D.I. 10) is GRANTED as follows:
`
`1.
`
`The above-captioned action is STAYED for no more than 90 days, absent further
`
`order of the Court;
`
`2.
`
`During the pendency of the stay, the Parties shall file joint status reports a minimum
`
`of every 30 days, starting from April 23, 2021 regarding developments in Seagen, Inc. v. Daiichi
`
`Sankyo Company, Limited, No. 2:20-cv-337 (E.D. Tex.) (the “Texas case”), irrespective of
`
`whether interim joint status reports are also filed; and
`
`3.
`
`During the pendency of the stay, the Parties shall file interim joint status reports to
`
`advise the Court in a timely matter of any developments in the Texas case—including, but not
`
`limited to, any decision rendered concerning venue—that may impact whether the stay in the
`
`above-captioned action should be lifted prior to the expiration of 90 days or extended past 90 days.
`
`_____________________________
` Chief, United States District Judge
`
`



